My guts saying will get some very attractive offers for the MDMA side of EMD business, and way to good to turn down IMO. Simply too many big names with deep pockets in and wanting in the psychedelics game, EMD shortcuts any serious players business timelines by years.
I can imagine EMD Director JV / acquisition Queen Karen Smith has a table full already
And EMD-RX5 and EMD-RX7 Skys the limit if TGA then FDA approves the OTC then Prescription capsules.
My guts saying will get some very attractive offers for the MDMA...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(3.26%) |
Mkt cap ! $18.20M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.5¢ | $21.39K | 460.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 269585 | 1 |
View Market Depth
| Last trade - 15.33pm 06/09/2024 (20 minute delay) ? |
| EMD (ASX) Chart |